Altimmune, Inc. Relocates Principal Executive Offices
Ticker: ALT · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1326190
| Field | Detail |
|---|---|
| Company | Altimmune, Inc. (ALT) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: administrative, office-move
TL;DR
Altimmune moved its HQ to Gaithersburg, MD on March 13, 2025.
AI Summary
On March 13, 2025, Altimmune, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878. This move is effective as of March 13, 2025.
Why It Matters
A change in principal executive offices can signal operational shifts or growth for a company. Investors should monitor if this move impacts operational efficiency or costs.
Risk Assessment
Risk Level: low — This filing is a routine administrative update regarding the company's office location and does not involve significant financial or operational changes.
Key Players & Entities
- Altimmune, Inc. (company) — Registrant
- 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878 (location) — New principal executive offices
- March 13, 2025 (date) — Effective date of office change
FAQ
What is the new address for Altimmune, Inc.'s principal executive offices?
The new address is 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878.
When was this change of address effective?
The change was effective as of March 13, 2025.
What type of filing is this for Altimmune, Inc.?
This is a Form 8-K, a current report filed with the SEC.
What was Altimmune, Inc.'s previous principal executive office location?
The filing does not explicitly state the previous address, only the new one.
What is the IRS Employer Identification Number for Altimmune, Inc.?
The IRS Employer Identification Number for Altimmune, Inc. is 20-2726770.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Altimmune, Inc. (ALT).